Lung Cancer Therapeutics Market By Cancer Type (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), By Treatment (Immunotherapy, Chemotherapy, Targeted Therapy, Radiation Therapy, and Others), By Drug Class (Antimetabolites, Alkylating Agents, Mitotic Inhibitors, EGFR Inhibitors, Multikinase Inhibitors, and Others), By End-User (Hospitals, Homecare, Specialty Clinics, and Others), and By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Internet, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Global lung cancer therapeutics market expected to generate around USD 42.24 billion by 2025, growing at a CAGR of around 13.2% between 2019 and 2025. Cancer is a disease caused by an uncontrolled division of abnormal cells in part of the body. These extra cells slowly gather together to form a tissue mass called a tumor.

23-Aug-2019 | Number of pages: 110 | Report Code: ZMR-4617 | Report Format : | Status : Published

Analysis

Cancer is a disease caused by an uncontrolled division of abnormal cells in part of the body. These extra cells slowly gather together to form a tissue mass called a tumor. It reduces the ability of lungs to supply oxygen to the bloodstream and lymphatic system. The leading cause of lung cancer is prolonged exposure to asbestos, cigarette, cigar, tobacco intake, pipe-smoking, exposer to pollution, and harmful radiations. The main symptoms of lung cancer are wheezing, coughing, chest pain, appetite loss, shortness of breath, and weight loss. Different therapies available for lung cancer include immunotherapy, vaccine therapy, radiation therapy, chemotherapy, and surgery.

The lung cancer therapeutics market is predicted grow substantially, owing to the growing number of people suffering from lung cancer, rising number of smokers, increasing exposure to asbestos, escalating demand for targeted therapies, presence of innovative and efficient drugs, and accelerating unhealthy lifestyle patterns. Additionally, the introduction of nano medication for lung cancer treatment is also driving the lung cancer therapeutics market globally. However, the high cost of drugs, negative effects of radiation therapies and chemotherapies, and poor cancer diagnostic facilities may limit the lung cancer therapeutics market.

Global Lung Cancer Therapeutics Market

The global lung cancer therapeutics market is fragmented based on cancer type, treatment, drug class, end-user, and distribution channel. Based on cancer type, the lung cancer therapeutics market includes small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). More than 85% of the lung cancers are found to be NSCLC. By treatment, the lung cancer therapeutics market includes immunotherapy, chemotherapy, targeted therapy, radiation therapy, and others. Based on drug class, the market is divided into multikinase inhibitors, EGFR inhibitors, alkylating agents, mitotic inhibitors, antimetabolites, and others. Antimetabolites are expected to show the highest CAGR in the future. Based on end-user, the lung cancer therapeutics market comprises hospitals, homecare, specialty clinics, and others. Based on distribution channel, the market for lung cancer therapeutics is categorized into retail pharmacy, hospital pharmacy, internet, and others.

North America will dominate the lung cancer therapeutics market over the forecast timeframe, owing to the increasing occurrences of lung cancer and rising geriatric population demanding therapeutics. Additionally, changing lifestyles and growing prevalence of smoking is leading to an escalating number of lung cancer incidences in North America. Europe is predicted to be the second-largest lung cancer therapeutics market, owing to the favorable government funding in the field of research, analysis and development of innovative medication, and technological growth related to cancer. The majority of the revenue of the Asia Pacific lung cancer therapeutics market is generated by the emerging nations of India and China, due to the growth in the number of smokers suffering from lung cancer.

Some of the key players in lung cancer therapeutics market include Hoffmann-La Roche, Eli Lilly and Company, Sanofi-Aventis, Pfizer, Celgene Corporation, GlaxoSmithKline Plc., Boehringer Ingelheim GmbH, Agennix AG, AstraZeneca Plc. and Merck & Co. among others.


Related Reports

Tissue Engineering Market by Application (Gynecology, Cell Banking & Cord blood, Dental, Urology, Integumentary & Skin, Cardiology, Neurology, Musculoskeletal, Orthopedics, & Spine, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5337 | Report Format:

The report covers forecast and analysis for the tissue engineering market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the tissue engineering ma...Read More

Robotic Prosthetic Market by Extremity (Upper Body Prosthetics and Lower Body Prosthetics), and Technology (Myoelectric Prosthetics and MPC Prosthetics): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-5336 | Report Format:

The report covers forecast and analysis for the robotic prosthetic market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the robotic prosthetic ...Read More

Long-Term Care Market by Service (Hospice, Home Healthcare, Assisted Living Facilities, Nursing care, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5335 | Report Format:

The report covers forecast and analysis for the long-term care market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the long-term care market alo...Read More

Leprosy Treatment Market by Drug Class (Antibacterial, Leprostatics, Antitubercular, Others), by Route of Administration (Oral, Injectable, Topical), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) – Global Industry Perspective Comprehensive Analysis and Forecast, 2020-2026

Mar-2020 | Price : $ 4199.00 | Pages: 135 | Report Code: ZMR-5334 | Report Format:

The report covers forecast and analysis for the Leprosy Treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Billion). The study includes drivers and restraints for the Leprosy Treatment ma...Read More

Hunter Syndrome Treatment Market by Treatment (Hematopoietic Stem Cell Transplant (HSCT), Enzyme Replacement Therapy (ERT), and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026

Mar-2020 | Price : $ 4199.00 | Pages: 126 | Report Code: ZMR-5333 | Report Format:

The report covers forecast and analysis for the hunter syndrome treatment market on a global and regional level. The study provides historic data from 2016 to 2019 along with forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the hunter syndrom...Read More

Request Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.